NO973589D0 - Medication for the treatment of obsessive compulsive problems, sleep apnea, sexual dysfunction, emesis and travel sickness - Google Patents

Medication for the treatment of obsessive compulsive problems, sleep apnea, sexual dysfunction, emesis and travel sickness

Info

Publication number
NO973589D0
NO973589D0 NO973589A NO973589A NO973589D0 NO 973589 D0 NO973589 D0 NO 973589D0 NO 973589 A NO973589 A NO 973589A NO 973589 A NO973589 A NO 973589A NO 973589 D0 NO973589 D0 NO 973589D0
Authority
NO
Norway
Prior art keywords
emesis
medication
treatment
sleep apnea
sexual dysfunction
Prior art date
Application number
NO973589A
Other languages
Norwegian (no)
Other versions
NO973589L (en
Inventor
Jordi Frigola Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO973589D0 publication Critical patent/NO973589D0/en
Publication of NO973589L publication Critical patent/NO973589L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO973589A 1995-12-12 1997-08-04 Drugs for the treatment of obsessive-compulsive disorder, sleep apnea, sexual dysfunction, emesis and travel sickness NO973589L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (en) 1995-12-12 1995-12-12 USE OF DERIVATIVES 1- (4- (4-ARYL (OR HETEROARYL) -1-PIPER AZINYL) -BUTY) -1H-AZOLE FOR THE TREATMENT OF DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS, SLEEP APNEA, SEXUAL DYSFUNCTIONS , Emese and motion sickness
PCT/EP1996/005736 WO1997021439A1 (en) 1995-12-12 1996-12-11 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness

Publications (2)

Publication Number Publication Date
NO973589D0 true NO973589D0 (en) 1997-08-04
NO973589L NO973589L (en) 1997-10-08

Family

ID=9485400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973589A NO973589L (en) 1995-12-12 1997-08-04 Drugs for the treatment of obsessive-compulsive disorder, sleep apnea, sexual dysfunction, emesis and travel sickness

Country Status (16)

Country Link
EP (1) EP0808166A1 (en)
JP (1) JPH11501051A (en)
CN (1) CN1177297A (en)
AR (1) AR004378A1 (en)
AU (1) AU716665B2 (en)
CA (1) CA2211161A1 (en)
CZ (1) CZ255197A3 (en)
ES (1) ES2134709B1 (en)
FR (1) FR2742052B1 (en)
HU (1) HUP9800198A2 (en)
IL (1) IL121461A0 (en)
NO (1) NO973589L (en)
PL (1) PL321779A1 (en)
TR (1) TR199700794T1 (en)
WO (1) WO1997021439A1 (en)
ZA (1) ZA9610457B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763950B1 (en) 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4- (4,5-DICHLORO-2-METHYLIMIDAZOL-1-YL) BUTYL] -1- PIPERAZINYL} -5-FLUOROPYRIMIDINE, ITS PREPARATION AND THERAPEUTIC USE
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
PT1309592E (en) 2000-08-14 2006-07-31 Ortho Mcneil Pharm Inc SUBSTITUTED PYRAZOLES
RU2317988C2 (en) 2000-08-14 2008-02-27 Орто-Макнейл Фармасьютикал, Инк. Substituted pyrazoles, pharmaceutical composition based on thereof, using pharmaceutical composition and method for inhibition of cathepsin s activity
PT1309591E (en) 2000-08-14 2007-04-30 Ortho Mcneil Pharm Inc Substituted pyrazoles
CN1642973A (en) 2000-09-06 2005-07-20 奥索-麦克尼尔药品公司 A method for treating allergies
JP4964593B2 (en) 2003-09-25 2012-07-04 セノメド バイオサイエンシーズ，エルエルシー Tetrahydroindolone derivatives for the treatment of neurological conditions
WO2005094827A1 (en) * 2004-03-30 2005-10-13 Kestrel Pharmaceuticals Inc. Methods for treating sexual dysfunction
DE602006012650D1 (en) 2005-04-26 2010-04-15 Hypnion Inc BENZISOXAZOLPIPERIDIN COMPOUNDS AND METHOD FOR THE APPLICATION
BRPI0610258A2 (en) 2005-04-26 2012-09-25 Hypnion Inc compound or a pharmaceutically effective salt thereof, pharmaceutical composition, and use of a compound
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
CN115304590B (en) * 2022-09-19 2024-05-28 皮摩尔新药(辽宁)有限公司 2H-benzotriazole derivatives, preparation method thereof and pharmaceutical composition containing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (en) * 1991-01-28 1995-05-24 Esteve Labor Dr DERIVATIVES OF ARYL (OR HETEROARYL) -PIPERAZINYL-ALKYL-AZOLES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.
FR2723091B1 (en) * 1994-07-29 1996-11-08 Esteve Labor Dr TETRAHYDROPYRIDINE- (6,4-HYDROXYPIPERIDINE) ALKYLAZOLES

Also Published As

Publication number Publication date
MX9706133A (en) 1997-11-29
ES2134709A1 (en) 1999-10-01
CZ255197A3 (en) 1998-01-14
ES2134709B1 (en) 2000-05-16
ZA9610457B (en) 1997-06-24
AU1376497A (en) 1997-07-03
HUP9800198A2 (en) 1999-09-28
JPH11501051A (en) 1999-01-26
CN1177297A (en) 1998-03-25
EP0808166A1 (en) 1997-11-26
AU716665B2 (en) 2000-03-02
FR2742052B1 (en) 1998-04-10
PL321779A1 (en) 1997-12-22
WO1997021439A1 (en) 1997-06-19
IL121461A0 (en) 1998-02-08
NO973589L (en) 1997-10-08
TR199700794T1 (en) 1997-11-21
FR2742052A1 (en) 1997-06-13
AR004378A1 (en) 1998-11-04
CA2211161A1 (en) 1997-06-19

Similar Documents

Publication Publication Date Title
PT1333887E (en) METHOD OF TREATMENT OF MUSCULAR DISORDERS
NO973589D0 (en) Medication for the treatment of obsessive compulsive problems, sleep apnea, sexual dysfunction, emesis and travel sickness
NO996483L (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
DE69524215T2 (en) RETRORE-REFLECTING BODY AND PRODUCTION METHOD
IT1307047B1 (en) EQUIPMENT FOR THE HUMIDIFIED TREATMENT OF THE SLEEP APNEA.
PL333118A1 (en) Pharmaceutical product method of sexual disease treatment and method of manufacturing of this pharmaceutical product
ZA951292B (en) 4-amino derivatives of mycophenolic acid
HK1026141A1 (en) Treatment of sleep apnea.
NO20011409L (en) Pharmaceuticals for the treatment of Parkinson's disease, ADHD and microadenomas
DE69527749T2 (en) Spherical activated carbon for the treatment of abdominal inflammation
NO994165D0 (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
MA25234A1 (en) VIBRATOR FOR THE RELIEF OF THE PAIN AND THE PAIN.
NO20014674L (en) Procedures for the treatment of neurological and neuropsychiatric disorders
DE69620691D1 (en) Therapeutic agent for the treatment of hypercholesterolemia
DE69519602D1 (en) Spherical activated carbon for the treatment of hemorrhoids
DE69735417D1 (en) 2,5-DIHYDROXYBENZYLSULFON DERIVATIVES FOR THE TREATMENT OF SEXUAL DISORDERS
EP1079764A4 (en) The treatment of sexual dysfunction in certain patient groups
LV11940A (en) The use of melatonin for the treatment of people who are dependent on grass
NO982562D0 (en) Composition for the treatment of pain
NO996060D0 (en) Breathing apparatus for the treatment of sleep apnea
NO20022990L (en) Method and composition for the treatment of pain
ID28817A (en) USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT
RU95122486A (en) MEANS FOR TREATMENT OF TICHOUS HYPERKINESIS
UA25336A (en) METHOD OF TREATMENT OF VENTURAL DISEASE OF THE REMOVAL AND DUODY
KR960030480U (en) Health Aid and Therapeutic Apparatus

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application